The efficacy of the antimalarial drug hydroxychloroquine for the treatment of coronavirus has not been confirmed by major studies. This was stated by the Director of the who health emergencies program, Michael Ryan, on July 29.
Ryan noted that although some positive effects were observed in small review studies, all large studies did not show a positive result when using hydroxychloroquine.
According to Ryan, there is numerous medical evidence that has found scientific confirmation that hydroxychloroquine “did not lead to an improvement in the condition of patients with confirmed coronavirus.”
The ineffectiveness against COVID-19 was also confirmed by the chief infectious disease specialist of the United States, Dr. Anthony Fauci, the BBC reported on July 29.
The Agency of the US Department of health and human services, which controls products and medicines, warned against using the drug in the treatment of coronavirus infection.
Hydroxychloroquine is a drug against malaria that has been used in some countries to treat patients with coronavirus.
In June, the world health organization (who) decided to stop testing of hydroxychloroquine as a drug against coronavirus.
The spread of SARS-CoV-2 coronavirus, which causes COVID-19 disease, began in December last year in the Chinese city of Wuhan. On March 11, the world health organization declared a pandemic.